Physician profile
Michael A Bernstein
NPI 1538376793
$6,763.48
in general payments reported to CMS, 2019-2025
10 companies · $5,341 in 2025
The $5,341 reported for 2025 was more than what 89% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $567 · 2020: $60.44 · 2021: $116 · 2022: $27.77 · 2023: $84.81 · 2024: $567 · 2025: $5,341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $1,507 · Food and Beverage: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $1,506.62 |
| Food and Beverage | $485.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,456.34 | 2024-2025 | |
| Ethicon INC. | $439.17 | 2019 | |
| Noah Medical Corporation | $397.24 | 2024 | Galaxy |
| Covidien Lp | $188.01 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $84.81 | 2023 | Fasenra |
| Abbott Laboratories | $68.77 | 2021 | |
| Glaxosmithkline, LLC. | $42.75 | 2021-2022 | |
| Ceribell, INC. | $34.86 | 2024 | Pocket Eeg Device |
| Medtronic, INC. | $32.17 | 2021 | |
| Electromed, INC. | $19.36 | 2025 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.